Dolphin Medical Services board to approve Kotha as chairman, Mallour reclassification

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Dolphin Medical Services Ltd holds board meeting on September 21, 2026
  • Agenda includes appointing Amarandhar Reddy Kotha as Chairman and Promoter Director
  • Rajesh Kumar Mallour to be reclassified from Professional to Promoter category
  • Reconstitution of Board Committees planned following leadership changes
  • Filings for Promoter Group reclassification subject to open offer compliances
powered bylight_fuzz_icon
51467264

*this image is generated using AI for illustrative purposes only.

Dolphin Medical Services Limited has scheduled a Board of Directors meeting for September 21, 2026, to consider significant changes in its leadership structure and promoter group composition. The session will focus on appointing Amarandhar Reddy Kotha as Chairman and Promoter Director, alongside the reclassification of Rajesh Kumar Mallour from Professional to Promoter category.

The company notified the Bombay Stock Exchange on September 20, 2026, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to commence at 11:00 am.

Key Agenda Items

The Board will transact the following businesses during the scheduled session:

  • Appointment of Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director, subject to applicable legal approvals.
  • Change of category for Rajesh Kumar Mallour (DIN: 07425226) from Professional to Promoter, pending requisite approvals.
  • Reconstitution of various Board Committees consequent to the proposed changes in Board composition.
  • Authorization for Rajesh Kumar Mallour to make necessary intimations and filings with stock exchanges and regulatory authorities regarding the proposed reclassification of the Promoter/Promoter Group. This is contingent upon completion of applicable open offer compliances under SEBI LODR regulations.

Rajesh Kumar Mallour, Director (DIN: 08215774), signed the intimation letter on behalf of the company.

How might the appointment of Amarandhar Reddy Kotha as Chairman influence Dolphin Medical Services' strategic direction and market positioning?

What are the potential implications for minority shareholders if the open offer compliances under SEBI LODR regulations are triggered by this promoter group reclassification?

Could the reconstitution of Board Committees lead to changes in corporate governance practices or risk management frameworks at Dolphin Medical Services?

like18
dislike

Dolphin Medical MD, CEO and two directors resign with immediate effect

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • G V Mohan Prasad resigned as Managing Director and CEO with immediate effect
  • Directors Lakshmi Sudha Madala and Dwarakanath Madala also stepped down
  • Resignations were accepted by the board on September 12, 2026
  • Outgoing officials cited professional commitments with no other material reasons
powered bylight_fuzz_icon
50767766

*this image is generated using AI for illustrative purposes only.

Dolphin Medical Services Limited saw significant leadership changes as Managing Director and CEO G V Mohan Prasad resigned from his post with immediate effect. Two other directors, Lakshmi Sudha Madala and Dwarakanath Madala, also stepped down during the same period.

The Board of Directors accepted these resignations in a meeting held on September 12, 2026. The session commenced at 7:00 pm and concluded at 7:20 pm IST. The board placed on record its appreciation for the contributions made by all three individuals during their respective tenures.

Resignation Details

The departures were formalized through separate resignation letters dated September 12, 2026. All three outgoing officials cited professional commitments or personal reasons without disclosing further material causes for their exit.

Name Designation DIN Effective Date
G V Mohan Prasad Managing Director & CEO 01236113 September 12, 2026
Lakshmi Sudha Madala Director 01235522 September 12, 2026
Dwarakanath Madala Director 00661146 September 12, 2026

G V Mohan Prasad confirmed in his resignation letter that there were no other material reasons for his departure aside from those mentioned. He requested the board to complete necessary statutory formalities with the Registrar of Companies and stock exchanges.

Lakshmi Sudha Madala and Dwarakanath Madala provided similar confirmations regarding their resignations. Dwarakanath Madala specifically noted his professional commitments as the driver for his exit. None of the resigning directors hold directorships in other listed entities, according to the disclosure annexures.

The company disclosed these developments pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information was filed with the Bombay Stock Exchange under scrip code 526504.

Who has been appointed as the interim CEO or Managing Director to ensure operational continuity during this leadership transition?

How might the simultaneous departure of the CEO and two directors impact Dolphin Medical Services' stock price and investor confidence in the short term?

What is the company's timeline for recruiting permanent replacements for the vacant board seats and executive roles?

like16
dislike

More News on Dolphin Medical Services Limited